Mesenchymal stromal cells protect human cardiomyocytes from amyloid fibril damage

BACKGROUND: Light chain (AL) amyloidosis is a protein misfolding disease characterized by extracellular deposition of immunoglobulin light chains (LC) as amyloid fibrils. Patients with LC amyloid involvement of the heart have the worst morbidity and mortality. Current treatments target the plasma ce...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cytotherapy
Main Authors: Lin, Yi, Marin-Argany, Marta, Dick, Christopher J., Redhage, Keely R., Blancas-Mejia, Luis M., Bulur, Peggy, Butler, Greg W., Deeds, Michael C., Madden, Benjamin J., Williams, Angela, Wall, Jonathan S., Dietz, Allan, Ramirez-Alvarado, Marina
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6456258/
https://ncbi.nlm.nih.gov/pubmed/29037943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcyt.2017.08.021
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki